Drugs / KOC1
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00632333 | Feb 2008 → Dec 2011 | esophageal cancer | Teikyo University | Unknown | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT00681577 | May 2008 → Oct 2009 | gastric cancer | Tokyo University | Completed | No outcome recorded |
| Phase 1/2 | NCT00674258 | May 2008 → Apr 2009 | non-small cell lung carcinoma | Tokyo University | Unknown | No outcome recorded |
| Phase 1/2 | NCT00681330 | May 2008 → Apr 2009 | esophageal cancer | Tokyo University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01267578 | Apr 2010 → May 2011 | esophageal cancer | University of Yamanashi | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KOC1 | “Biological/Vaccine: URLC10, CDCA1, and KOC1 peptides” NCT01267578 ↗ |
| Modality | Vaccine | “Peptide Vaccine” NCT00674258 ↗ |
| Route | Subcutaneous | “administered by subcutaneous injection” NCT00674258 ↗ |